2001
DOI: 10.1159/000045896
|View full text |Cite
|
Sign up to set email alerts
|

A Potential Role of Peritoneal Dialysis as ‘a Bridging Therapy’ to Other Renal Replacement Therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2002
2002
2007
2007

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…With respect to modality selection in diabetic patients, the individual history of diabetes and any accompanying comorbidities must be considered. Therapy that is more individualized and linked to the concept of integrated ESRD care allows for the two dialysis modalities and kidney transplantation all to be considered at each phase of active ESRD treatment (11).…”
Section: Peritoneal Dialysis In Diabetic Patientsmentioning
confidence: 99%
“…With respect to modality selection in diabetic patients, the individual history of diabetes and any accompanying comorbidities must be considered. Therapy that is more individualized and linked to the concept of integrated ESRD care allows for the two dialysis modalities and kidney transplantation all to be considered at each phase of active ESRD treatment (11).…”
Section: Peritoneal Dialysis In Diabetic Patientsmentioning
confidence: 99%
“…Since the transplantation rate is rather low in Japan, most patients rely on long-term dialysis therapy. Although EPS in Japan is not common in PD patients, the frequency of EPS increases with time on dialysis, and this affects patients’ and doctors’ attitudes against choosing long-term PD for patients (13). Furthermore, PD may be more expensive than HD in Japan (14).…”
Section: Utilization Of Pd In Asia and Its Limiting Factorsmentioning
confidence: 99%
“…They also suggested that cultural factors lead to patients not selecting PD (2). Kuriyama believes that Japanese patients are not equally informed about PD as a treatment option (3). Kurokawa also notes that there is too little financial incentive for doctors, hospitals, or dialysis clinics to promote PD to patients (2).…”
mentioning
confidence: 99%